Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Renal Denervation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Renal Denervation Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Renal Denervation Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Renal Denervation Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Renal Denervation Catheters Overview
  • Products under Development
    • Renal Denervation Catheters - Pipeline Products by Stage of Development
      • Table Renal Denervation Catheters - Pipeline Products by Stage of Development
      • Table Renal Denervation Catheters - Pipeline Products by Stage of Development
    • Renal Denervation Catheters - Pipeline Products by Segment
      • Table Renal Denervation Catheters - Pipeline Products by Segment
      • Table Renal Denervation Catheters - Pipeline Products by Segment
    • Renal Denervation Catheters - Pipeline Products by Territory
      • Table Renal Denervation Catheters - Pipeline Products by Territory
      • Table Renal Denervation Catheters - Pipeline Products by Territory
    • Renal Denervation Catheters - Pipeline Products by Regulatory Path
      • Table Renal Denervation Catheters - Pipeline Products by Regulatory Path
      • Table Renal Denervation Catheters - Pipeline Products by Regulatory Path
    • Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
      • Table Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
      • Table Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
    • Renal Denervation Catheters - Ongoing Clinical Trials
      • Table Renal Denervation Catheters - Ongoing Clinical Trials
      • Table Renal Denervation Catheters - Ongoing Clinical Trials
  • Renal Denervation Catheters - Pipeline Products under Development by Companies
    • Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
      • Table Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
    • Renal Denervation Catheters - Pipeline Products by Stage of Development
      • Table Renal Denervation Catheters - Pipeline Products by Stage of Development
  • Renal Denervation Catheters Companies and Product Overview
    • Abbott Vascular Inc Company Overview
      • Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chemical RDN System - Product Status
        • Table Chemical RDN System - Product Description
    • Ablative Solutions Inc Company Overview
      • Ablative Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ablative Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peregrine System Kit - Hypertension - Product Status
        • Table Peregrine System Kit - Hypertension - Product Description
        • Table Ablative Solutions Inc - Ongoing Clinical Trials Overview
        • Table Peregrine System Kit - Hypertension - A Pivotal, Multicenter, Blinded, Sham procedure-Controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects with Hypertension
    • Brattea Company Overview
      • Brattea Pipeline Products & Ongoing Clinical Trials Overview
        • Table Brattea Pipeline Products & Ongoing Clinical Trials Overview
        • Table Netrod System - Product Status
        • Table Netrod System - Product Description
    • CryoMedix, LLC. Company Overview
      • CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Catheter Based Cryoablation System - Product Status
        • Table Catheter Based Cryoablation System - Product Description
    • Handok-Kalos Medical Company Overview
      • Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table DENEX - Product Status
        • Table DENEX - Product Description
        • Table Handok-Kalos Medical - Ongoing Clinical Trials Overview
        • Table DENEX - A Prospective, Multicenter, No-treatment Controlled, Randomized, Open-label, Pivotal Study to Evaluate the Safety and Efficacy of DENEX, Renal Denervation Therapy, in Patients with Hypertension on no or 1-3 Antihypertensive Medications
        • Table DENEX - A Prospective, Multicenter, Sham-controlled, Single-blinded, Randomized, Pilot Study to Evaluate the Safety and Effectiveness of DENEX Renal Denervation System in Patients With Uncontrolled Hypertension Not Treated With Anti-HTN Medication
    • Johns Hopkins University Company Overview
      • Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flexible Renal Denervation Ablation Device - Product Status
        • Table Flexible Renal Denervation Ablation Device - Product Description
    • Kona Medical Inc Company Overview
      • Kona Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kona Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Surround Sound System - Product Status
        • Table Surround Sound System - Product Description
    • Lepu Medical Technology (Beijing) Co Ltd Company Overview
      • Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Disposable Intravascular Ultrasound Ablation Catheter - Product Status
        • Table Disposable Intravascular Ultrasound Ablation Catheter - Product Description
        • Table Renal Denervation System - Product Status
        • Table Renal Denervation System - Product Description
        • Table Lepu Medical Technology (Beijing) Co Ltd - Ongoing Clinical Trials Overview
        • Table Disposable Intravascular Ultrasound Ablation Catheter - First in Man Study to Evaluate the Safety and Efficacy of Disposable Intravascular Ultrasound Ablation Catheters and Ultrasound Ablation Instrument in the Treatment of Essential Hypertension
    • Lifetech Scientific (Shenzhen) Co Ltd Company Overview
      • Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renal Denervation Catheter - Product Status
        • Table Renal Denervation Catheter - Product Description
    • Mayo Clinic Company Overview
      • Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pressure Wire - Product Status
        • Table Pressure Wire - Product Description
    • Medtronic Plc Company Overview
      • Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Symplicity Renal Denervation System - Product Status
        • Table Symplicity Renal Denervation System - Product Description
        • Table Symplicity Spyral Renal Denervation System - Product Status
        • Table Symplicity Spyral Renal Denervation System - Product Description
        • Table Medtronic Plc - Ongoing Clinical Trials Overview
        • Table Symplicity Renal Denervation System - Global SYMPLICITY Registry (GSR) Denervation Findings in Real World (DEFINE)
        • Table Symplicity Renal Denervation System - Renal Denervation in Patients with Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation (REDE-AF): A National, Multi-Centre, Prospective, Single-arm, Pre-to-post Treatment, Medical-Device Study
        • Table Symplicity Renal Denervation System - Study Evaluating the Clinical Evidence of Symplicity
        • Table Symplicity Spyral Renal Denervation System - Cardiac Sympathetic Neuromodulation by Renal Denervation in Hypertrophic Cardiomyopathy (SNYPER Pilot Study)
        • Table Symplicity Spyral Renal Denervation System - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multielectrode Renal Denervation System in Patients with Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTNON MED)
        • Table Symplicity Spyral Renal Denervation System - Prairie Renal Denervation Study: Renal Denervation (RDN) for Management of Patients with Loin Pain Hematuria Syndrome (LPHS)
        • Table Symplicity Spyral Renal Denervation System - Renal Nerve Simulation Guided Renal Sympathetic Denervation with Siymplicity Spyral Radiofrequency Catheter for Resistant Hypertension: a Feasibility Study
        • Table Symplicity Spyral Renal Denervation System - The SPYRAL AFFIRM Global Clinical Study of Renal Denervation with the Symplicity Spyral Renal Denervation System in Subjects with Uncontrolled Hypertension (SPYRAL AFFIRM)
        • Table Symplicity Spyral Renal Denervation System - The Systemic Effects of Transcatheter Renal Artery Sympathetic Denervation Using a Second- Generation Radiofrequency Ablation Catheter: A Multicenter Observational Study.
    • MicroPort Scientific Corp Company Overview
      • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table FlashPoint Renal Artery RF Ablation Catheter - Product Status
        • Table FlashPoint Renal Artery RF Ablation Catheter - Product Description
        • Table MicroPort Scientific Corp - Ongoing Clinical Trials Overview
        • Table FlashPoint Renal Artery RF Ablation Catheter - 3D Cardiac Electrophysiological Mapping System on Renal Artery Radiofrequency Ablation System for Hypertension: a Prospective, Multicenter, Randomized Controlled Trial
    • Northwind Medical Inc Company Overview
      • Northwind Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Northwind Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Guidewire Based Catheter - Product Status
        • Table Guidewire Based Catheter - Product Description
    • Rainmed Medical Ltd Company Overview
      • Rainmed Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rainmed Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flash RDN System - Product Status
        • Table Flash RDN System - Product Description
    • ReCor Medical Inc Company Overview
      • ReCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ReCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Paradise Ultrasound Renal Denervation System - Product Status
        • Table Paradise Ultrasound Renal Denervation System - Product Description
        • Table ReCor Medical Inc - Ongoing Clinical Trials Overview
        • Table Paradise Ultrasound Renal Denervation System - A Clinical Study of the Ultrasound Renal Denervation System (PRDS-001) in Patients With Hypertension
        • Table Paradise Ultrasound Renal Denervation System - Clinical Study of an Ultrasound Renal Denervation System in Patients with Heart Failure
        • Table Paradise Ultrasound Renal Denervation System - Effect of Renal Denervation in Hypertensive Patients With Autosomal Dominant Polycystic Kidney Disease
        • Table Paradise Ultrasound Renal Denervation System - Radiance Trio Continued Access Protocol (TRIO CAP): A Study of the ReCor Medical Paradise System in Clinical Hypertension
        • Table Paradise Ultrasound Renal Denervation System - Reducing Sympathetic Activity Through Ultrasound-based Renal Denervation in Excessive Cardiovascular Risk Populations - the RESURRECT Trial. A Pilot Proof-of-concept and Safety Study With the Paradise Denervation System
        • Table Paradise Ultrasound Renal Denervation System - Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients with Uncontrolled Hypertension: the RESTART Study
        • Table Paradise Ultrasound Renal Denervation System - The "Global Paradise System" Registry
        • Table Paradise Ultrasound Renal Denervation System - The Global Paradise(R) System US Post Approval Study (US GPS)
        • Table Paradise Ultrasound Renal Denervation System - Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation - Redo Ablation Procedures: A Pilot Study
    • Renal Dynamics, LLC Company Overview
      • Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table ReDy Renal Denervation System - Product Status
        • Table ReDy Renal Denervation System - Product Description
    • Renaly Ltd Company Overview
      • Renaly Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renaly Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renal Artery Denervation System - Product Status
        • Table Renal Artery Denervation System - Product Description
    • Shanghai AngioCare Medical Technology Co Ltd Company Overview
      • Shanghai AngioCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shanghai AngioCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Allegro Renal Denervation System - Product Status
        • Table Allegro Renal Denervation System - Product Description
        • Table Iberis Second-Generation Renal Sympathetic Denervation System - Product Status
        • Table Iberis Second-Generation Renal Sympathetic Denervation System - Product Description
    • Shanghai Golden Leaf Medtech Co Ltd Company Overview
      • Shanghai Golden Leaf Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shanghai Golden Leaf Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renal Denervation System - Hypertension - Product Status
        • Table Renal Denervation System - Hypertension - Product Description
        • Table Shanghai Golden Leaf Medtech Co Ltd - Ongoing Clinical Trials Overview
        • Table Renal Denervation System - Hypertension - Clinical Mechanism of Endovascular Denervation (EDN) for the Treatment of Type 2 Diabetes
    • SoniVie Ltd. Company Overview
      • SoniVie Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table SoniVie Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therapeutic Intra-Vascular Ultrasound (TIVUS) System - Renal Artery Denervation - Product Status
        • Table Therapeutic Intra-Vascular Ultrasound (TIVUS) System - Renal Artery Denervation - Product Description
        • Table SoniVie Ltd. - Ongoing Clinical Trials Overview
        • Table Therapeutic Intra-Vascular Ultrasound (TIVUS) System - Renal Artery Denervation - Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS) System for Renal Denervation in Patients with Uncontrolled Stage 2 Hypertension
    • Sound Interventions, Inc. Company Overview
      • Sound Interventions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sound Interventions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ultrasound Renal Denervation System - Product Status
        • Table Ultrasound Renal Denervation System - Product Description
    • St. Jude Medical LLC Company Overview
      • St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Third Generation EnligHTN Renal Denervation System - Product Status
        • Table Third Generation EnligHTN Renal Denervation System - Product Description
    • Suzhou Xinmai Medical Equipment Co Ltd Company Overview
      • Suzhou Xinmai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Suzhou Xinmai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table SyMapCath I Catheter - Product Status
        • Table SyMapCath I Catheter - Product Description
        • Table Suzhou Xinmai Medical Equipment Co Ltd - Ongoing Clinical Trials Overview
        • Table SyMapCath I Catheter - A Prospective, Multicenter, Single Blind, Randomized and Controlled Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension (SMART Trial)
        • Table SyMapCath I Catheter - A Prospective, Single-center, Open-label, Self Controlled Case Series Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension in Patients on Hemodialysis: SMART-HD Trial
    • Symple Surgical Inc Company Overview
      • Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DirectAblate Renal Denervation System - Product Status
        • Table DirectAblate Renal Denervation System - Product Description
    • Tel Aviv University Company Overview
      • Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Catheter System - Arterial Stiffness - Product Status
        • Table Catheter System - Arterial Stiffness - Product Description
    • Terumo Interventional Systems Company Overview
      • Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
        • Table Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
        • Table Renal Sympathetic Denervation System - TRI Technique - Product Status
        • Table Renal Sympathetic Denervation System - TRI Technique - Product Description
    • University of Sydney Company Overview
      • University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mu Catheter - Product Status
        • Table Mu Catheter - Product Description
    • Venus Medtech Hangzhou Inc Company Overview
      • Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Echomplish Device - Product Status
        • Table Echomplish Device - Product Description
    • Verve Medical, Inc. Company Overview
      • Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Verve Medical Phoenix System - Product Status
        • Table Verve Medical Phoenix System - Product Description
        • Table Verve Medical, Inc. - Ongoing Clinical Trials Overview
        • Table Verve Medical Phoenix System - Natural Orifice via Renal Pelvis Denervation (Novel- Denervation) Pivotal IDE Trial for the Treatment of Uncontrolled Hypertension to Lower Blood Pressure
  • Renal Denervation Catheters- Recent Developments
    • Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team
    • Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024
    • May 07, 2024: Medtronic's renal denervation system receives approval in China
    • Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer
    • Apr 18, 2024: Recor Medical Announces First Cases of Paradise Ultrasound Renal Denervation Therapy in the United Arab Emirates
    • Apr 11, 2024: Ablative Solutions' TARGET BP I Pivotal Trial Results Demonstrate Significant Reduction in 24-Hour Ambulatory Systolic Blood Pressure Compared to Sham, Using Alcohol-Mediated Renal Denervation
    • Mar 14, 2024: Tampa General Hospital Employs New Ultrasound Therapy Designed to Treat Life-Threatening Hypertension
    • Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
    • Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
    • Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
    • Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
    • Feb 16, 2024: Jim Robo, Former Chairman and CEO of NextEra Energy, to Join Mayo Clinic Board of Trustees
    • Feb 07, 2024: Terumo Announces Change of Executive Officers (PDF 232.27 KB)
    • Feb 02, 2024: SoniVie completes enrolment in renal denervation study
    • Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
    • Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    • Dec 22, 2023: Medtronic Launches Symplicity Blood Pressure Procedure - A new Horizon in Managing Patients with Hypertension in India
    • Dec 19, 2023: Ablative Solutions Announces Primary Endpoint Met in the TARGET BP I Pivotal Trial of the Peregrine System Kit for Patients with Uncontrolled Hypertension
    • Dec 13, 2023: MarinHealth Interventional Cardiologists Are First on the West Coast to Perform Symplicity Renal Denervation Procedure Outside of a Clinical Trial
    • Dec 09, 2023: Baylor Scott & White Heart and Vascular Hospital - Dallas Deploys FDA-Approved Hypertension Treatment
    • Nov 28, 2023: Medtronic Obtains Pre-Market Approval (PMA) For Symplicity Spyral Renal Denervation System
    • Nov 28, 2023: First Patient Treated With Medtronic Symplicity Spyral Renal Denervation System at Piedmont
    • Nov 17, 2023: Medtronic Announces FDA Approval of Minimally Invasive Device to Treat Hypertension
    • Nov 16, 2023: ReCor Medical Obtains Pre-Market Approval (PMA) for Paradise Ultrasound Renal Denervation System
    • Nov 13, 2023: Recor Medical introduces Paradise uRDN system in US
    • Nov 08, 2023: Recor Medical receives FDA approval for hypertension treatment system
    • Oct 27, 2023: Positive six-month follow-up results for Recor's renal denervation system
    • Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
    • Oct 20, 2023: Recor Medical to Present Latest Clinical Data on Paradise Ultrasound Renal Denervation at TCT Annual Meeting
    • Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
    • Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
    • Aug 23, 2023: Medtronic Issues Statement on the FDA Circulatory Systems Devices Advisory Panel Vote for the Symplicity Spyral Renal Denervation System
    • Aug 22, 2023: Otsuka Medical Devices and Recor Medical Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension
    • Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion
    • Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
    • Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
    • Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
    • Jul 14, 2023: ReCor Responds to European Society of Hypertension's (ESH) Updated Guidelines for Management of Arterial Hypertension
    • Jul 11, 2023: Verve Medical Announces FDA Approval of IDE for Pivotal Trial of RPD Renal Pelvic Denervation System for Treatment of Uncontrolled Hypertension
    • Jul 03, 2023: Medtronic Statement on ESH Guidelines for Hypertension and Renal Denervation
    • Jun 30, 2023: Bioheart Announces Clinical Result for Iberis-HTN at CIT 2023
    • Jun 27, 2023: Kalos Medical Receives Korean MFDS Innovative Medical Device Designation for DENEX Hypertension Treatment System
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings